Search research articles
Contact Us
Filters
Showing results (181-190 of 205) with videos related to
Page
of 21
Sort By:
Journal for Immunotherapy of Cancer
|
January 28, 2022
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
Brie Chun, Joanna Pucilowska, ShuChing Chang, et al.
Disease Models & Mechanisms
|
February 3, 2022
Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data
Baharak Ahmaderaghi, Raheleh Amirkhah, James Jackson, et al.
Nature Communications
|
March 1, 2014
Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly
J Majkut, M Sgobba, C Holohan, et al.
Journal for Immunotherapy of Cancer
|
June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy
Ryan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.
Cancer Immunology Research
|
January 27, 2021
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Mark D Badeaux, Annah S Rolig, Giulia Agnello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Philip D Dunne, Sonali Dasgupta, Jaine K Blayney, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Seminars in Oncology
|
November 16, 2010
Signaling through OX40 enhances antitumor immunity
Shawn M Jensen, Levi D Maston, Michael J Gough, et al.
Cancer Research Communications
|
July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures
Umair Mahmood, Andrew Blake, Sanjay Rathee, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 205) with videos related to
Sort By:
Page
of 21
Journal for Immunotherapy of Cancer
|
January 28, 2022
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer
Brie Chun, Joanna Pucilowska, ShuChing Chang, et al.
Disease Models & Mechanisms
|
February 3, 2022
Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data
Baharak Ahmaderaghi, Raheleh Amirkhah, James Jackson, et al.
Nature Communications
|
March 1, 2014
Differential affinity of FLIP and procaspase 8 for FADD's DED binding surfaces regulates DISC assembly
J Majkut, M Sgobba, C Holohan, et al.
Journal for Immunotherapy of Cancer
|
June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy
Ryan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.
Cancer Immunology Research
|
January 27, 2021
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Mark D Badeaux, Annah S Rolig, Giulia Agnello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2015
EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
Philip D Dunne, Sonali Dasgupta, Jaine K Blayney, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Seminars in Oncology
|
November 16, 2010
Signaling through OX40 enhances antitumor immunity
Shawn M Jensen, Levi D Maston, Michael J Gough, et al.
Cancer Research Communications
|
July 18, 2024
Stratification to Neoadjuvant Radiotherapy in Rectal Cancer by Regimen and Transcriptional Signatures
Umair Mahmood, Andrew Blake, Sanjay Rathee, et al.
JCI Insight
|
June 30, 2026
A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of sarcoma
Jianguo Huang, Xingliang Liu, Warren Floyd, et al.
Page
of 21